Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Seattle, Washington
- Most recent report
- 8-K, filed Sep 24, 2026
- Incorporated
- Delaware
- Filings on record
- 732 filings
- On EDGAR
- CIK 1671584
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 44
News 8 of 164
Prospectuses and Registrations 8 of 59
- S-8 Registration statement for an employee plan Sep 25, 2026
- 424B4 Final prospectus for an offering Sep 3, 2026
- S-1 Registration statement for an offering Aug 21, 2026
- S-8 Registration statement for an employee plan Jul 24, 2026
- 424B4 Final prospectus for an offering Jan 30, 2026
- S-1 Registration statement for an offering Jan 28, 2026
- 424B4 Final prospectus for an offering Nov 25, 2025
- S-1 Registration statement for an offering Oct 1, 2025
Proxies 8 of 37
- DEF 14A Proxy statement for a shareholder vote Aug 31, 2026
- PRE 14A Preliminary proxy statement Aug 21, 2026
- DEF 14A Proxy statement for a shareholder vote Jul 31, 2026
- DEF 14A Proxy statement for a shareholder vote Jan 26, 2026
- PRE 14A Preliminary proxy statement Jan 16, 2026
- DEF 14A Proxy statement for a shareholder vote Jul 3, 2025
- PRE 14A Preliminary proxy statement Jun 23, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
Ownership 8 of 329
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4 Insider reported a trade Aug 10, 2026
- 4 Insider reported a trade Aug 10, 2026
- 4 Insider reported a trade Aug 10, 2026
- 4 Insider reported a trade Aug 10, 2026
- 4 Insider reported a trade Aug 10, 2026
- 4 Insider reported a trade Aug 10, 2026
- 4 Insider reported a trade Aug 10, 2026
Other 8 of 99
- EFFECT Notice that a registration became effective Sep 2, 2026
- D Aug 26, 2026
- ARS Annual report sent to shareholders Jul 31, 2026
- EFFECT Notice that a registration became effective Jan 30, 2026
- CORRESP Reply to SEC staff Jan 29, 2026
- UPLOAD Comment letter from SEC staff Jan 29, 2026
- EFFECT Notice that a registration became effective Nov 25, 2025
- CORRESP Reply to SEC staff Nov 24, 2025
Everything here comes from Aptevo Therapeutics Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.